MicroRNA-127 post-transcriptionally downregulates Sept7 and suppresses cell growth in hepatocellular carcinoma cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1537-1546

  Zhou, Jiansheng ^a   Lu, Shan ^a   Yang, Shengsheng ^a   Chen, Huan ^a   Shi, Hanping ^b   Miao, Mingyong ^a   Jiao, Binghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

HCC; MiR 127; Sept7

Indexed keywords

MICRORNA; MICRORNA 127; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; MIRN127 MICRORNA, HUMAN; SEPT7 PROTEIN, HUMAN; SEPTIN; ALPHA FETOPROTEIN; LUCIFERASE; SEPT7 PROTEIN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE TARGETING; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; PRIORITY JOURNAL; RNA TRANSCRIPTION; SUPPRESSOR CELL; WESTERN BLOTTING; ANIMAL; DEFICIENCY; DOSE RESPONSE; GENETICS; LIVER TUMOR; MOUSE; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL CULTURE; TUMOR SUPPRESSOR GENE; ANIMAL CELL; ANIMAL MODEL; CANCER PATIENT; CARCINOGENICITY; CARCINOMA CELL; CELL METABOLISM; CLINICAL ARTICLE; CORRELATIONAL STUDY; GENE EXPRESSION; GENE REPRESSION; GROWTH INHIBITION; HUMAN CELL; NONHUMAN; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MICE; MICRORNAS; SEPTINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84901357167     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358717     Document Type: Article

References (32)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin D: Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010;127:2893-2917.
2. Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, Heathcote J, Piratsivuth T, Kew M, Otegbayo J, Zheng S, Sarin S, Hamid S, Modawi S, Fleig W, Fedail S, Thomson A, Kha n A, Malfertheiner P, Lau G, Carillo F, Krabshuis J, Le Mair A, World Gastroenterology O: Hepatocellular carcinoma (hcc): A global perspective. J Clin Gastroenterol 2010;44:239-245.
3. Farazi P DePinho R Hepatocellular carcinoma pathogenesis: From genes to environment Nat Rev Cancer 2006 6 674-687. (Pubitemid 44286000)
4. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K: Comprehensive analysis of microrna expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-2545.
5. Bartel D: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
6. Ambros V: The functions of animal micrornas. Nature 2004;431:350-355. (Pubitemid 39265675)
7. Calin G, Dumitru C, Shimizu M, Bichi R, Zupo S, N och E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce C: Frequent deletions and down-regulation of micro-rna genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-15529. (Pubitemid 35403967)
8. Calin GA, Croce CM: Microrna signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
9. Khare S, Zhang Q, Ibdah JA: Epigenetics of hepatocellular carcinoma: Role of microrna. World J Gastroenterol 2013;19:5439-5445.
10. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, C roce CM, Qin L-X, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang Z-Y, Sun H-C, Wang X-W: Microrna expression, survival, and response to interferon in liver cancer. N Engl J Med 2009;361:437-447.
11. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein M, Tuschl T, Margalit H: Clustering and conservation patterns of human micrornas. Nucleic Acids Res 2005;33:26 97-2706. (Pubitemid 41511287)
12. Kircher M, Bock C, Paulsen M: Structural conservation versus functional divergence of maternally expressed micrornas in the dlk1/gtl2 imprinting region. BMC Genomics 2008;9:346.
13. Bha skaran M, Wang Y, Zhang H, Weng T, Baviskar P, Guo Y, Gou D, Liu L: Microrna-127 modulates fetal lung development. Physiol Genomics 2009;37:268-278.
14. Pan C, Chen H, Wang L, Ya ng S, Fu H, Zheng Y, Miao M, Jiao B: Down-regulation of mir-127 facilitates hepatocyte proliferation during rat liver regeneration. PloS one DOI: 10.1371/journal.pone.0039151.
15. Chen J, Wang M, Guo M, Xie Y, Cong Y-S: Mir-127 regulates cell proliferation and senescence by targeting bcl6. PloS one DOI: 10.1371/journal.pone.0080266.
16. Yang Z-H, Zhang Y, Wang L: A feedback inhibition between mirna-127 and tgfb/c-jun cascade in hcc cell migration via mmp13. PloS one DOI: 10.1371/journal.pone.0065256.
17. Tryndyak V, Ross S, Beland F, Pogribny I: Down-regulation of the micrornas mir-34a, mir-127, and mir-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog 2009;48:479-4 87.
18. Saito Y, Liang G, Egger G, Friedman J, Chuang J, Coetzee G, Jones P: Specific activation of microrna-127 with downregulation of the proto-oncogene bcl6 by chromatin-modifying drugs in human cancer cells. Cancer ce ll 2006;9:435-443. (Pubitemid 43832188)
19. Guo LH, Li H, Wang F, Yu J, He J-S: The tumor suppressor roles of mir-433 and mir-127 in gastric cancer. Int J Mol Sci 2013;14:14171-14184.
20. Roessl er S, Jia H-L, Budhu A, Forgues M, Ye Q-H, Lee JS, Thorgeirsson S, Sun Z, Tang Z-Y, Qin L-X, Wang X: A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinom a patients. Cancer Res 2010;70:10202-10212.
21. Meltzer P: Cancer genomics: Small rnas with big impacts. Nature 2005;435:745-746. (Pubitemid 40839710)
22. Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert B, Mak R, Ferrando A, Downing J, Jacks T, Horvitz H, Golub T: Microrna expression profiles classify human cancers. Nature 2005;435:834-838. (Pubitemid 40839735)
23. Jiang H, Jin C, Liu J, Hua D, Zhou F, Lou X, Zhao N, Lan Q, Huang Q, Yoon JG, Zheng S, Lin B: Next generation sequencing analysis of mirnas: Mir-127-3p inhibits glioblastoma proliferation and activa tes tgf-p signaling by targeting ski. OMICS 2014;18:196-206.
24. Zhang C Wang C Chen X Yang C Li K Wang J Dai J Hu Z Zhou X Chen L Zhang Y Li Y Qiu H Xing J Liang Z Ren B Yang C Zen K Zhang C-Yi Expression profile of micrornas in serum: A fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010;56 1871-1879 879
25. Kartmann B, Roth D: Novel roles for mammalian septi ns: From vesicle trafficking to oncogenesis J Cell Sci 2001 114 839-844. (Pubitemid 32266256)
26. Kinoshita M: Assembly of mammalian septins. J Biochem 2003;134:491-496. (Pubitemid 37442871)
27. Mostowy S, Cossart P: Septins: The fourth component of the cytoskeleton. Nat Rev Mol Cell Biol 2012;13:183-194.
28. Jia Z-F, Huang Q, Kang C-S, Yang W-D, Wang G-X, Yu S-Z, Jiang H, Pu P-Y: Overexpression of sep tin 7 suppresses glioma cell growth. J Neurooncol 2010;98:329-340.
29. Jia Z, Wang K, Wang G, Zhang A, Pu P: Mir-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting sept7. PloS one DOI: 10.1371/journal.pone.0055008.
30. Ball D, Rose E, Alpert E: Alpha-fetoprotein levels in normal adults. Am J Med Sci 1992;303:157-159.
31. Blumberg B, Larouze B, London W, Werner B, Hesser J, Millman I, Saimot G, Payet M: The relation of infection with the hepatitis b agent to primary hepatic carcinoma. Am J Pathol 1975;81:669-682.
32. Tateishi R, Yoshida H, Matsuyama Y, Mine N, Kondo Y, Omata M: Diagnostic accuracy of tumor markers for hepatocellular carcinoma: A systematic review. Hepatol Int 2008;2:17-30. (Pubitemid 351250400)